News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
Measuring epigenetic signatures in blood plasma could help classify brain tumors, according to a study published in Nature Medicine.
Lurie Cancer Center is pleased to announce that Adam Lin, MD, PhD, has been selected by the American Society of Hematology (ASH) to participate in the 2020 ASH Clinical Research Training Institute (CRTI).
My cancer journey began when I was diagnosed with a stage 3/4 (Synovial/soft tissue) sarcoma in 2013 at age 23.
- Lurie Cancer Center at Northwestern Memorial Hospital Ranked #8 in the Nation by U.S. News & World Report07.28.2020
The Lurie Cancer Center at Northwestern Memorial Hospital is ranked #8 in the nation by U.S. News & World Report in its 2020-2021 list of Best Hospitals for Cancer. Lurie Cancer Center is also recognized once again as the #1 cancer program in Illinois and Chicago.
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
Northwestern Medicine investigators have discovered that the growth of cancerous tumors requires the activation of a specific biochemical process within the mitochondria of tumor cells, showing potential as a new target for cancer therapy.
Losing weight during COVID-19 pandemic is urgent as obesity increases risk of severe disease and death
A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.
Cancer patients with other comorbidities have a higher risk of dying from complications due to COVID-19, and should discuss the risks and benefits of continuing cancer treatment with their physician, according to a recent study.
A novel drug called enzalutamide may extend overall survival for men with nonmetastatic, castration-resistant prostate cancer, according to findings from clinical trial published in The New England Journal of Medicine.
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
A protein called mDia2 is vital for proper bone marrow transplantation, according to a new study.
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
A genetic screen has revealed previously unknown regulators of Foxp3, a transcription factor that, when deactivated, may improve patient response to aggressive cancers.
Congratulations to Desiree West, RN, Lead Infusion Nurse in Lurie Cancer Center’s Maggie Daley Center for Women’s Cancer Care in Prentice Women’s Hospital, for receiving the first Northwestern Medical Group DAISY Nursing Award on Northwestern Medicine’s Chicago campus!
Northwestern Medicine scientists have discovered an alternate mechanism for aberrant gene splicing that contributes to T-cell lymphoblastic leukemia, according to a recent study.
Virtual Cancer Survivors’ Celebration Walk & 5K
June 7, 2020 marked an important milestone for 15-year-old Charlie and his family. For months they’d been planning to celebrate Charlie’s 15th “cancerversary” as a retinoblastoma survivor at their 15th Cancer Survivors’ Celebration Walk & 5K.
In women with early-stage breast cancer, Northwestern Medicine investigators found chemoendocrine therapy was associated with greater cognitive impairment at three and six months compared to endocrine therapy alone.
The Lurie Cancer Center stands with the Association of American Cancer Institutes and strongly condemns any form of racism and discrimination. Please read the full statement below, urging that these issues be confronted as public health crises. Racism has no place in any civilized society and must end once and for all.
See more news in the article archive.